netFormulary Isle of Wight NHS
Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.03.02  Expand sub section  Drugs for arrhythmias
02.03.02  Expand sub section  Supraventricular arrhythmias
02.03.02  Expand sub section  Supraventricular and ventricular arrhythmias
Amiodarone
View adult BNF View SPC online View childrens BNF
First Choice
Yellow

Monitoring of patients taking amiodarone

System Reason Monitoring
Thyroid and endocrine Amiodarone is known to affect thyroid function due to iodine content. All patients taking amiodarone must have TFTs checked on a 6 monthly basis, and after discontinuation due to long half life- See SPC for details
Eyes

Most patients develop corneal micro-deposits, which are reversible on stopping treatment. These rarely interfere with vision but can affect night time driving.

If optic neuritis or neuropathy develops treatment must be stopped.

Complete ophthalmic examination is recommended immediately if blurred vision is reported. Otherwise patients will require annual ophthalmic assessments
Electrolyte

Potassium levels

Should be checked before initiating treatment
Chest

Known pulmonary toxicity resulting in dyspnoea and non-productive cough

Chest X ray is required before treatment

Any toxicity is reversed on discontinuation

Liver

Associated with hepatotoxicity

LFTs before treatment and every 6 months whilst taking.

ECG and resuscitation facilities need to be available before administering IV amiodarone

 

 

 
Disopyramide
View adult BNF View SPC online View childrens BNF
Formulary
Yellow

Antimuscarinic effects can limit use in patients diagnosed with angle-closure glaucoma or prostatic hyperplasia

Monitor for:

Hypotension, hypoglycaemia, ventricular tachycardia or fibrillation or torsades de pointes (discontinue if occurs) and serum potassium

 
   
Flecainide
View adult BNF View SPC online View childrens BNF
Formulary
Yellow

Use with caution as may precipitate serious arrhythmias in a small number of patients.

 

 
   
02.03.02  Expand sub section  Ventricular arrhythmias
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Drugs that may be initiated, stabilised and maintained by primary, secondary or tertiary care Secondary and tertiary care prescribing may be continued by primary care. [this does not indicate first/second line choice]  

Green Hospital

Items used by the Hospital but would not normally be continued into primary care. Primary care prescribers can change to GREEN first or second.   

Green plus

Initiation of drugs by primary care following written advice from secondary/ tertiary care advice.  

Yellow

Drugs that may be continued in primary care following initiation and stabilisation in secondary/tertiary care  

Amber

Items requiring a shared care agreement. These items should be initiated and stabilised by secondary or tertiary care. The GP should only be asked to take over prescribing through a formal shared care agreement. Secondary care will be expected to continue prescribing until the agreement is made.  

Red

Hospital/ Trust ONLY. These are items the secondary and tertiary care are responsible for prescribing and will need to continue to prescribe for long term maintenance. These items will NOT be prescribed in primary care. But primary care should be informed the patient is receiving these items. This will include NHSE funded items requiring repatriation.  

GP - Black

Items covered by NHSE ‘Should not prescribe in primary care list’ – See CCG policy on Drugs of limited clinical value  

GP - Grey

Grey List: Items covered by NHSE ‘Should not prescribe in primary care list’ that are not to be routinely prescribed but may be suitable in a defined population – See CCG policy on Drugs of limited clinical value  

netFormulary